Tag Archives: Pharma

Pharma Throws Greece Another Lifeline. Will Greece Reciprocate?

Greece took its part on Wednesday in the latest widespread strikes against austerity measures that swept across Europe, throwing travel networks into disarray and sparking violent clashes between police and workers. But for once Greece wasn’t at the forefront of the misery as the country has been thrown a couple more lifelines — not least […]
Posted in Europe, Global | Also tagged , , , , | Leave a comment

Taxing Times for French Pharma

By Nathan Jessop. While French politics has taken a decisive shift to the left with the election of the country’s first socialist president for 17 years, it does not look like Francois Hollande will be changing or derailing any of the existing — and sometimes quite radical — healthcare reforms that the outgoing Nicolas Sarkozy had […]
Posted in Global, Guest Blog | Also tagged , , , , , | Leave a comment

Uncertain Outlook for Pharma and Biotech Deals Following 'Turbulent' 2011

Peter Young, President and Managing Director of international investment bank Young & Partners, looks at what lies ahead for pharma and biotech following a turbulent 2011. The business outlook for pharma companies for the rest of 2012 and beyond is mixed, as pharma companies struggle to realign themselves to a new business model that will […]
Posted in Global, Guest Blog, leadership, Strategy | Also tagged , , , , | Leave a comment

The Real Way to Lean Success: Suck Out the IT Fat

The bigger the company, the thicker the sclerosis, the more they need to suck out the fat, writes Bill Drummy. Consider this: In 2011, IMS projects US Rx market growth to be 2.7 percent. The top 10 pharma companies account for 50 percent of the entire market’s revenue, but will deliver only 10 percent of […]
Posted in Guest Blog, Strategy, Technology | Also tagged , | Leave a comment

Croatia: A New Hope for European Pharma?

With Croatia’s potential accession to the EU gathering pace, Beth Kennedy looks at the implications for pharma. The growth in overall healthcare expenditure in Croatia is slow and the percentage of GDP is expected to remain the same, but the country’s accession to the EU means that European pharma would have access to cheap products […]
Posted in Emerging Markets, Europe, Global, Guest Blog, healthcare, Market Access | Also tagged , | Leave a comment
  • Categories

  • Meta